NASDAQ
BG Medicine, Inc. (BGMD) has a free cash flow growth of -236.45% as of Friday, May 29, 2026. This represents a 890.99% decrease compared to its 12-month average of 29.89%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.